E71.0
Maple-syrup-urine disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Maple Syrup Urine Disease (MSUD) is a rare genetic disorder that affects how the body processes certain amino acids. Named after the distinctive smell of affected infants’ urine, MSUD can lead to serious neurological issues if not diagnosed and managed early. This condition is inherited in an autosomal recessive pattern, meaning both parents must carry and pass on the defective gene for a child to be affected.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting enzymes responsible for breaking down branched-chain amino acids (leucine, isoleucine, and valine). Inheritance of two copies of the defective gene, one from each parent.
Key Symptoms: Sweet-smelling urine reminiscent of maple syrup Poor feeding in infants Vomiting Lethargy and irritability Extreme sleepiness Drop in blood sugar levels (hypoglycemia) Delayed development and muscular weakness Seizures Loss of consciousness in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis often begins with newborn screening programs that test for metabolic disorders, including MSUD, shortly after birth. Confirmatory tests include blood and urine analyses to detect elevated levels of branched-chain amino acids and their corresponding keto acids. Genetic testing can identify mutations in the BCKDHA, BCKDHB, or DBT genes, which encode components of the enzyme complex involved in amino acid breakdown. Ongoing monitoring of amino acid levels helps guide management and treatment adjustments.
Treatment Protocols: Management of Maple Syrup Urine Disease primarily involves dietary regulation and, when necessary, medical interventions. These include: - Strict dietary restrictions limiting intake of branched-chain amino acids - Special formulas designed to provide essential nutrients without the problematic amino acids - Regular monitoring of amino acid levels in blood and urine - Supplementation with certain vitamins and cofactors as recommended by healthcare providers - In some cases, liver transplantation has been considered as a treatment option to restore enzyme activity - Prompt treatment of metabolic crises with intravenous fluids, glucose, and medications to balance amino acids and prevent neurological damage Early diagnosis and consistent management are crucial in preventing severe complications and improving quality of life for individuals with MSUD.
Clinical Advice & FAQs
Billing Guidance
Is E71.0 a billable ICD-10 code?
Yes, E71.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.0?
Clinical documentation must specify the nature of Maple-syrup-urine disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference